| Primary |
| Breast Cancer Metastatic |
38.1% |
| Breast Cancer |
25.7% |
| Hypertension |
12.4% |
| Chemotherapy |
6.2% |
| Prophylaxis |
2.7% |
| Dyspepsia |
1.8% |
| Neoplasm |
1.8% |
| Abdominal Discomfort |
0.9% |
| Blood Cholesterol |
0.9% |
| Bone Pain |
0.9% |
| Cough |
0.9% |
| Crohn's Disease |
0.9% |
| Depression |
0.9% |
| Gout |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Hyperglycaemia |
0.9% |
| Metastatic Neoplasm |
0.9% |
| Oestrogen Receptor Positive Breast Cancer |
0.9% |
| Osteoporosis |
0.9% |
| Sleep Disorder |
0.9% |
|
| Ejection Fraction Decreased |
10.8% |
| Atrial Fibrillation |
8.1% |
| Cardiac Failure |
8.1% |
| Pulmonary Embolism |
8.1% |
| Cholecystitis Acute |
5.4% |
| Endometrial Cancer |
5.4% |
| Hepatic Function Abnormal |
5.4% |
| Hypersensitivity |
5.4% |
| Neutrophil Count Decreased |
5.4% |
| Pleural Effusion |
5.4% |
| Respiratory Failure |
5.4% |
| Vomiting |
5.4% |
| Cerebrovascular Accident |
2.7% |
| Cystitis |
2.7% |
| Death |
2.7% |
| Fatigue |
2.7% |
| Infection |
2.7% |
| Nausea |
2.7% |
| Oesophagitis |
2.7% |
| Osteomyelitis |
2.7% |
|
| Secondary |
| Breast Cancer |
45.0% |
| Breast Cancer Metastatic |
23.8% |
| Pain |
3.8% |
| Metastases To Bone |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Drug Use For Unknown Indication |
2.5% |
| Hormone Therapy |
2.5% |
| Breast Ductal Cancer Infiltrating |
1.5% |
| Hypertension |
1.5% |
| Invasive Ductal Breast Carcinoma |
1.5% |
| Breast Cancer Stage Iv |
1.3% |
| Metastatic Neoplasm |
1.3% |
| Vitamin Supplementation |
1.3% |
| Her-2 Positive Breast Cancer |
1.1% |
| Nausea |
1.1% |
| Prophylaxis |
1.1% |
| Toxic Nodular Goitre |
1.1% |
| Breast Cancer Female |
0.9% |
| Lung Neoplasm Malignant |
0.9% |
| Constipation |
0.8% |
|
| Hepatic Failure |
18.8% |
| Weight Decreased |
10.9% |
| Hepatic Cirrhosis |
7.8% |
| Cerebrovascular Accident |
6.3% |
| Cutaneous Vasculitis |
6.3% |
| Peripheral Motor Neuropathy |
6.3% |
| Cardiac Cirrhosis |
4.7% |
| Productive Cough |
4.7% |
| Suicidal Ideation |
4.7% |
| Wound Secretion |
4.7% |
| Ejection Fraction Decreased |
3.1% |
| Metastases To Central Nervous System |
3.1% |
| Pulmonary Embolism |
3.1% |
| Skin Lesion |
3.1% |
| Toxicity To Various Agents |
3.1% |
| Urinary Tract Infection |
3.1% |
| Ascites |
1.6% |
| Cerebral Ischaemia |
1.6% |
| Cholecystitis |
1.6% |
| Convulsion |
1.6% |
|
| Concomitant |
| Breast Cancer |
21.1% |
| Metastases To Bone |
17.8% |
| Breast Cancer Metastatic |
14.4% |
| Breast Neoplasm |
6.7% |
| Pain |
5.6% |
| Osteoporosis |
5.0% |
| Bone Loss |
4.4% |
| Hypertension |
4.4% |
| Nausea |
2.8% |
| Drug Use For Unknown Indication |
2.2% |
| Her-2 Positive Breast Cancer |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Diabetes Mellitus |
1.7% |
| Hormone Therapy |
1.7% |
| Insomnia |
1.7% |
| Neoplasm Malignant |
1.7% |
| Anxiety |
1.1% |
| Cardiovascular Event Prophylaxis |
1.1% |
| Complex Partial Seizures |
1.1% |
| Depression |
1.1% |
|
| Osteonecrosis |
22.2% |
| Tooth Extraction |
13.0% |
| Vomiting |
7.4% |
| Alanine Aminotransferase Increased |
3.7% |
| Alopecia |
3.7% |
| Breast Cancer Metastatic |
3.7% |
| Cardiotoxicity |
3.7% |
| Disease Progression |
3.7% |
| Epilepsy |
3.7% |
| Fatigue |
3.7% |
| Nasal Septum Deviation |
3.7% |
| Osteonecrosis Of Jaw |
3.7% |
| Recall Phenomenon |
3.7% |
| Tachyarrhythmia |
3.7% |
| Tooth Abscess |
3.7% |
| Toothache |
3.7% |
| Weight Decreased |
3.7% |
| Abdominal Distension |
1.9% |
| Aortic Calcification |
1.9% |
| Bone Pain |
1.9% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Delirium |
12.5% |
| Bone Pain |
8.3% |
| Hormone Therapy |
8.3% |
| Neoplasm Malignant |
8.3% |
| Arthralgia |
4.2% |
| Pain In Extremity |
4.2% |
| Sedation |
4.2% |
|
|
